Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Biological Activity Cagrilintide and semaglutide, when co-administered, produce synergistic reductions in bodyweight (up to ~1517% over 2032 weeks in clinical trials) and significant improvements in glycemic parameters, including HbA1c and fasting glucose
In a 4-week phase 1 study using a MAD design in participants with T2D, comparing treatment against dulaglutide and placebo, target doses of 0.3 mg, 1.5 mg, and 4.5 mg achieve mean weight loss of 0.3%, 2.6%, and 3.0%, respectively, with 2.2% mean weight loss for the dulaglutide group and 1.0% for placebo (66)
Gentle Process The GHK-Cu bypasses your digestive system entirely, which means no stomach upset
FAST-ACTING ABSORPTION: Unlike traditional tablets, these drinkable oral vials allow for faster nutrient uptake, ensuring your nervous system and energy levels receive the support they need without the wait
Current Pharmaceutical Design
US$ 24.04
US$ 21.07
US$ 22.24
US$ 24.21
US$ 22.78
US$ 22.85
US$ 25.69
